Our breakthrough, proprietary technology platform engineered to enhance drug absorption
End-to-end, in-house control of formulation, development, and manufacturing capabilities
Our proprietary cannabinoid composition for the management of pain and inflammation
Partnering with the world’s leading research institutions and doctors to support FDA-authorized investigator-initiated clinical trials
Learn more about cannabidiol from the medical community and regulators
We are modernizing the way medicines are taken
Experts in drug development and delivery, manufacturing, and commercialization
Recent media coverage regarding Orcosa
Company news and announcements
Ewing, N.J. – July 28, 2025 – Orosa Inc. (“Orcosa”), a life-sciences company modernizing the way medicines are taken through the Rapid Infusion Technology (RITe™) Platform, today announced that Vincent T. Mileto, Co-Founder and Chief Operating Officer, has been named to NJBIZ’s 2025 People to Watch in Health Care list, recognizing innovators whose work is advancing patient care across New Jersey.
Published on July 14, the NJBIZ list highlights professionals making outsized contributions to their organizations and to the health of the state, often before they receive broad public recognition. NJBIZ emphasized Mileto’s work developing the RITe Platform, and its potential to create life-changing therapies for patients who have difficulty swallowing traditional medications.
“I’m honored by NJBIZ’s recognition,” said Vincent. “I appreciate the acknowledgement, but this is really a recognition of our team. We’re just getting started, and will remain focused on translating our platform into patient-friendly products that improve treatment outcomes and provide value to the health system.”
About the NJBIZ People to Watch in Health Care List
NJBIZ compiles its Watch Lists based on editorial reporting, expert input and reader recommendations, spotlighting individuals whose professional accomplishments and service advance the public interest. Read the NJBIZ announcement and full list here.
About Orcosa Inc.
Orcosa is a life-sciences company modernizing the way medicines are taken and improving patient outcomes through its proprietary therapeutic delivery technology, the Rapid Infusion Technology (RITe™) Platform – a fast-acting, easy-to-take tablet engineered to enhance drug absorption. Orcosa’s lead program, ORAVEXX™, is a non-addictive proprietary cannabidiol composition being evaluated for pain management. For more information, visit Orcosa.com.
Media Contact
media@orcosa.com
Investor Contact
IR@orcosa.com